Laxygal

Sodium picosulfate, the active ingredient in Laxygal, is a stimulant laxative presented as an oral preparation for oral use. It treats constipation and is employed for bowel preparation before colonoscopy in adult patients.

GNH USA supplies Laxygal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Laxygal (sodium picosulfate) is a stimulant laxative used to manage conditions affecting colonic transit.

- Constipation: facilitates bowel movements by increasing intestinal peristalsis and water content. - Bowel preparation for colonoscopy: clears the colon to allow clear visualization during the procedure. - Pre‑surgical bowel cleansing: prepares the colon before certain abdominal surgeries to reduce fecal load.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Abdominal cramps: mild to moderate discomfort in the abdomen. - Diarrhea: increased loose stools. - Nausea: feeling of queasiness. - Flatulence: excess gas production. - Thirst: increased desire for fluids. - Electrolyte imbalance: mild changes in serum electrolytes.

Serious or Rare Side Effects: - Severe dehydration: marked loss of body fluids. - Significant electrolyte disturbances: notable shifts in potassium or sodium levels. - Allergic reaction: rash, itching, or swelling. - Colitis: inflammation of the colon. - Rectal bleeding: presence of blood in stool. - Severe abdominal pain: intense, persistent pain.

Before initiating therapy, consider the following safety measures. - Assess bowel function: ensure patient is not already experiencing obstruction. - Avoid use in intestinal blockage: contraindicated in mechanical obstruction. - Caution with electrolyte disorders: monitor serum electrolytes in at‑risk patients. - Pediatric use: limit to children only under medical supervision. - Concomitant laxatives: do not combine with other stimulant or osmotic laxatives. - Store at ambient temperature: keep in the original pack, protect from moisture.

Drug interactions may alter efficacy or safety.

Major Interactions (Avoid): - Anticholinergic agents: may reduce laxative effect. - Opioid analgesics: counteract stimulant action on the colon. - Mineral oil: can impair absorption of the drug.

Moderate Interactions (Monitor Closely): - Diuretics: increase risk of electrolyte imbalance. - Cardiac glycosides: electrolyte changes may affect cardiac function. - Antacids: may alter colonic pH and affect drug activation.